Market News: Zydus Cadila Receives Tentative Approval | Nifty Adds a Distribution Day

Today’s Action

Nifty, -0.8%; Sensex, -1%; Nifty Midcap, +1.3%; Nifty Smallcap, +1.3%; Model Portfolio, -0.2%

Market Pulse Confirmed Uptrend

Nifty, after a gap up opening, traded in a narrow range in the first half of the trading session. However, the index shed all its gains in the last hour of the day and closed in negative territory. Further, Nifty added a distribution day as today’s volume was higher than the previous session.

On the sectoral front, results were mixed. Nifty Financial Service and Nifty Bank were the major decliners, which lost more than 2% each. On the flip side, Nifty FMCG (+4.1%) gained the most followed by Nifty Realty (+1.8%). The advance-decline ratio was in favor of advancers. Of 2,111 stocks traded, 1,208 advanced, 588 declined, and the remaining traded flat.

We continue to be very selective about taking any fresh positions. It is important that investors don’t play all their cards at once. We would suggest adopting an investment approach where you begin with a small allocation and increase it as and when the market advances further.

Without trying to predict and decode stories, we will take what the market gives us and continue to monitor unfolding conditions. Stocks with higher relative strength and superior fundamentals can do well. Some leading stocks have sharply corrected. Wait for them to put in at least a short period of consolidation and show a constructive breakout from that range. Buying without this period of constructive behavior into a straight upmove off the bottom, puts you at a risk of drawdown.

Key News

Lupin (Nse)(-1.9%) received the Establishment Inspection Report after closure of the U.S. FDA inspection of the company’s Mandideep Unit II facility, classifying the inspection as Voluntary Action Indicated.

Cadila Healthcare(-4.1%) received tentative approval from the U.S. FDA for Macitentan tablets.

Continue reading with a MarketSmith India Premium subscription…

To Read Detailed Reports including Stock Recommendations, Idea Lists, Evaluate Stocks etc. Subscribe to MarketSmith India

Disclaimer: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. It is for educational purposes only.

Daily Big Picture:Nifty Ends Below 9,000; Pharma Index Up 45% From its Lows

Today’s Action

Nifty, -1.3%; Sensex, -1.5%; Nifty Midcap, -1.4%; Nifty Smallcap, -0.6%; Model Portfolio, +0.9%

Market Pulse Confirmed Uptrend

Nifty opened on a flat note and quickly lost around 100 points and made an intraday low of 8,912. However, it pared some of its losses and closed slightly below 9,000. Nifty escaped distribution as today’s volume was lower than the previous session. 

Barring Nifty Pharma (+2.8%) and Metal (+1.9%), all sectoral indices closed in the red. Nifty Pharma rallied ~45% from its lows. On the flip side, Nifty Realty (-4.9%), Media (-3.3%) and Financial Services (-3.1%) were the major decliners. The advance-decline ratio was in favor of advancers. Of 2,126 stocks traded, 952 advanced, 854 declined, and the remaining traded flat.

We continue to be very selective about taking any fresh positions. It is important that investors don’t play all their cards at once. We would suggest adopting an investment approach where you begin with a small allocation and increase it as and when the market advances further. 

Without trying to predict and decode stories, we will take what the market gives us and continue to monitor unfolding conditions. Stocks with higher relative strength and superior fundamentals can do well. Some leading stocks have sharply corrected. Wait for them to put in at least a short period of consolidation and show a constructive breakout from that range. Buying without this period of constructive behavior into a straight upmove off the bottom, puts you at a risk of drawdown.

Key News

According to SIAM data, passenger vehicles sales for FY20 declined 18% whereas it declined 51% y/y for March. Commercial vehicles sales declined 29% for FY20 and 88% for March.

Dr Reddys Labs. (Nse) launched the blood cancer drug Invista in India. These tablets are used for the treatment of Chronic Myeloid Leukemia.

Bandhan Bank’s total deposits grew 32% y/y to Rs 57,073 in FY20. Retail deposits grew 34% in the same period and form 78.4% of the total deposits.

Disclaimer: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. It is for educational purposes only.

Market Update: After 7 Weeks of Decline, Nifty Finally Sees Weekly Gain

Weekly Action

Nifty, +12.7%; Sensex, +12.9%; Nifty Midcap, +10.9%; Nifty Smallcap, +9.6%; Model Portfolio, +2.1%.

Market Pulse Confirmed Uptrend

Weekly Market Review

Nifty made a halt to seven straight weeks of decline and closed the week with a gain of more than 12%. The index started the week on a strong positive note and recorded additional follow through day as it gained about 8.8%, on higher volume than the previous session. The index closed in negative on Wednesday. Today, Nifty staged a reversal and closed the day near the day’s high holding significant gains.

All the sectoral indices closed in positive territory for the week. Nifty Auto (+23.1%) led the gains followed by Nifty Pharma (+19.4%) which continued the gaining momentum. Further, Financial stocks staged a reversal with Nifty Pvt Bank, Nifty Bank, and Nifty Financial gaining more than 14% each.

We continue to be very selective about taking any fresh positions. It is important that investors don’t play all their cards at once. We would suggest adopting an investment approach where you begin with a small allocation and increase it as and when the market advances further. Without trying to predict and decode stories, we will take what the market gives us and continue to monitor unfolding conditions. Stocks with higher relative strength and superior fundamentals can do well. Some leading stocks have sharply corrected. Wait for them to put in at least a short period of consolidation and show a constructive breakout from that range. Buying without this period of constructive behavior into a straight upmove off the bottom puts you at the risk of a drawdown.

Disclaimer: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. It is for educational purposes only.

Daily Big Picture: Nifty at an intraday high of 8,576; as Lupin receives a nod from USFDA

Today’s Action

Nifty, -4.4%; Sensex, -4.6%; Nifty Midcap, -2.8%; Nifty Smallcap, -2.3%; Model Portfolio, 0%

Daily Market Review

Market Pulse: Rally Attempt

Nifty, after opening around 300 points lower, surged higher to make an intraday high of 8,576. However, as the day progressed, it continued to decline to end below 8,300. Today’s action has put an end to the last four session’s rally. 76% of Nifty 50 stocks have declined, with Bajaj Finance (-11.8%) and Housing Development Fin. (-11.1%) being the major decliners.

Continue reading “Daily Big Picture: Nifty at an intraday high of 8,576; as Lupin receives a nod from USFDA”

Weekly Big Picture : DHFL Reports its Q3 Results. Get the best stock market predictions here

Weekly Action

Nifty, -0.3%; Sensex, -0.2%; Nifty Midcap, -0.2%; Nifty Smallcap, +0.04%; and Model Portfolio, +1.7%.

Market Pulse Rally Attempt

Weekly Market Review

After closing below 50-DMA last Friday, Nifty started the week on a weaker note. It was volatile through the week. Today, it tested its 50-DMA (12,148) but couldn’t close above it. Also, the broader market was weak. Nifty Midcap and Smallcap bounced back from their 50-DMA.

Continue reading “Weekly Big Picture : DHFL Reports its Q3 Results. Get the best stock market predictions here”